ELV Elevance Health Inc

Price (delayed)

$506.97

Market cap

$117.96B

P/E Ratio

19.98

Dividend/share

$6.07

EPS

$25.38

Enterprise value

$136.55B

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately ...

Highlights
ELV's gross profit is up by 10% year-on-year
The company's revenue rose by 9% YoY
ELV's P/E is 17% above its 5-year quarterly average of 17.1 and 14% above its last 4 quarters average of 17.6
Elevance Health's debt has increased by 4.2% YoY

Key stats

What are the main financial stats of ELV
Market
Shares outstanding
232.67M
Market cap
$117.96B
Enterprise value
$136.55B
Valuations
Price to book (P/B)
3.03
Price to sales (P/S)
0.7
EV/EBIT
15.62
EV/EBITDA
13.02
EV/Sales
0.8
Earnings
Revenue
$171.34B
EBIT
$8.74B
EBITDA
$10.49B
Free cash flow
$6.77B
Per share
EPS
$25.38
Free cash flow per share
$28.79
Book value per share
$167.29
Revenue per share
$729.23
TBVPS
$312.13
Balance sheet
Total assets
$108.93B
Total liabilities
$69.52B
Debt
$25.12B
Equity
$39.31B
Working capital
$18.24B
Liquidity
Debt to equity
0.64
Current ratio
1.44
Quick ratio
1.3
Net debt/EBITDA
1.77
Margins
EBITDA margin
6.1%
Gross margin
17.3%
Net margin
3.5%
Operating margin
5.1%
Efficiency
Return on assets
5.5%
Return on equity
15.6%
Return on invested capital
18.6%
Return on capital employed
13%
Return on sales
5.1%
Dividend
Dividend yield
1.2%
DPS
$6.07
Payout ratio
23.9%

ELV stock price

How has the Elevance Health stock price performed over time
Intraday
1.38%
1 week
-1.44%
1 month
-1.19%
1 year
4.65%
YTD
7.51%
QTD
-2.23%

Financial performance

How have Elevance Health's revenue and profit performed over time
Revenue
$171.34B
Gross profit
$29.72B
Operating income
$8.75B
Net income
$5.99B
Gross margin
17.3%
Net margin
3.5%
ELV's gross profit is up by 10% year-on-year
The company's revenue rose by 9% YoY
Elevance Health's net margin has decreased by 8% YoY and by 2.8% from the previous quarter
The operating margin has declined by 6% year-on-year

Growth

What is Elevance Health's growth rate over time

Valuation

What is Elevance Health stock price valuation
P/E
19.98
P/B
3.03
P/S
0.7
EV/EBIT
15.62
EV/EBITDA
13.02
EV/Sales
0.8
ELV's P/E is 17% above its 5-year quarterly average of 17.1 and 14% above its last 4 quarters average of 17.6
Elevance Health's EPS has increased by 3.3% YoY
ELV's price to book (P/B) is 17% higher than its 5-year quarterly average of 2.6 and 8% higher than its last 4 quarters average of 2.8
The equity has increased by 8% YoY and by 2.3% from the previous quarter
ELV's P/S is 17% above its last 4 quarters average of 0.6
The company's revenue rose by 9% YoY

Efficiency

How efficient is Elevance Health business performance
Elevance Health's return on sales has decreased by 6% YoY
ELV's ROE is down by 4.9% YoY and by 2.5% QoQ
Elevance Health's return on assets has decreased by 5% YoY
Elevance Health's ROIC has decreased by 4.6% YoY and by 2.1% from the previous quarter

Dividends

What is ELV's dividend history
DPS
$6.07
Dividend yield
1.2%
Payout ratio
23.9%
Recent dividends

Financial health

How did Elevance Health financials performed over time
The total assets is 57% higher than the total liabilities
The total assets rose by 6% YoY
The total liabilities is up by 4.7% year-on-year but it has declined by 3.4% since the previous quarter
Elevance Health's debt is 36% less than its equity
The equity has increased by 8% YoY and by 2.3% from the previous quarter
Elevance Health's debt has increased by 4.2% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.